Lyell Immunopharma, Inc. LYEL Q4 2025 Annual earnings

FAQ

When did Lyell Immunopharma, Inc. report Q4 2025 earnings?

Lyell Immunopharma, Inc. (LYEL) reported Q4 2025 earnings on March 12, 2026 before market open.

What were Lyell Immunopharma, Inc.'s Q4 2025 revenue and EPS?

Lyell Immunopharma, Inc. reported revenue of $6.0K and eps of $-7.68 for Q4 2025.

Did Lyell Immunopharma, Inc. beat estimates in Q4 2025?

Revenue missed the consensus estimate of $15.3K by $9.3K. EPS missed the consensus estimate of $-2.15 by $5.53.

How did Lyell Immunopharma, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 45.5% from $11.0K a year earlier and eps declined 966.7% from $-0.72.

Where can I find Lyell Immunopharma, Inc.'s Q4 2025 SEC filings?

You can read the 8-K earnings release (0001193125-26-097615) and the 10-K periodic report (0001628280-26-017253) directly on SEC EDGAR. The filing index links above go to sec.gov.